Jean-Pierre Delord

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 12

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Cancer research communications

Investigational new drugs

Cancer chemotherapy and pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Michael R Paillasse, Michael Esquerré, Florie A Bertrand, Céline Poussereau-Pomié, Mélanie Pichery, Virgile Visentin, Geneviève Gueguen-Dorbes, Florence Gaujarengues, Pauline Barron, Gaelle Badet, Anne Briaux, Pierre-Benoit Ancey, David Sibrac, Eric Erdociain, Dennis Özcelik, Jérôme Meneyrol, Valérie Martin, Anne Gomez-Brouchet, Janik Selves, Philippe Rochaix, Maxime Battistella, Céleste Lebbé, Jean-Pierre Delord, Frédérique Dol-Gleizes, Françoise Bono, Isabelle Blanc, Antoine Alam, Ian Hunneyball, Mark Whittaker, Pierre Fons
Targeting Tumor Angiogenesis with the Selective VEGFR-3 Inhibitor EVT801 in Combination with Cancer Immunotherapy. Cancer research communications 2 (11) (2022)
Michael R Paillasse, Michael Esquerré, Florie A Bertrand, Céline Poussereau-Pomié, Mélanie Pichery, Virgile Visentin, Geneviève Gueguen-Dorbes, Florence Gaujarengues, Pauline Barron, Gaelle Badet, Anne Briaux, Pierre-Benoit Ancey, David Sibrac, Eric Erdociain, Dennis Özcelik, Jérôme Meneyrol, Valérie Martin, Anne Gomez-Brouchet, Janik Selves, Philippe Rochaix, Maxime Battistella, Céleste Lebbé, Jean-Pierre Delord, Frédérique Dol-Gleizes, Françoise Bono, Isabelle Blanc, Antoine Alam, Ian Hunneyball, Mark Whittaker, Pierre Fons
Targeting Tumor Angiogenesis with the Selective VEGFR-3 Inhibitor EVT801 in Combination with Cancer Immunotherapy. Cancer research communications 2 (11) (2022)
Vivek Subbiah, Irene Brana, Alessandra Longhi, Valentina Boni, Jean-Pierre Delord, Ahmad Awada, Pascaline Boudou-Rouquette, John Sarantopoulos, Geoffrey I Shapiro, Anthony D Elias, Ravin Ratan, Cristian Fernandez, Carmen Kahatt, Martin Cullell-Young, Mariano Siguero, Ali Zeaiter, Sant P Chawla
Antitumor Activity of Lurbinectedin, a Selective Inhibitor of Oncogene Transcription, in Patients with Relapsed Ewing Sarcoma: Results of a Basket Phase II Study. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (13) (2022)
Daniel P Petrylak, Yohann Loriot, David R Shaffer, Fadi Braiteh, John D Powderly, Lauren C Harshman, Paul Conkling, Jean-Pierre Delord, Michael Gordon, Joseph W Kim, Indrani Sarkar, Kobe Yuen, Edward E Kadel, Sanjeev Mariathasan, Carol O'Hear, Sujata Narayanan, Marcella Fassò, Susheela Carroll, Thomas Powles
Safety and Clinical Activity of Atezolizumab in Patients with Metastatic Castration-Resistant Prostate Cancer: A Phase I Study. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (12) (2021)
Anne Montfort, Thomas Filleron, Mathieu Virazels, Carine Dufau, Jean Milhès, Cécile Pagès, Pascale Olivier, Maha Ayyoub, Muriel Mounier, Amélie Lusque, Stéphanie Brayer, Jean-Pierre Delord, Nathalie Andrieu-Abadie, Thierry Levade, Céline Colacios, Bruno Ségui, Nicolas Meyer
Combining Nivolumab and Ipilimumab with Infliximab or Certolizumab in Patients with Advanced Melanoma: First Results of a Phase Ib Clinical Trial. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (4) (2020)
Jonathan Strosberg, Nobumasa Mizuno, Toshihiko Doi, Enrique Grande, Jean-Pierre Delord, Ronnie Shapira-Frommer, Emily Bergsland, Manisha Shah, Marwan Fakih, Shunji Takahashi, Sarina A Piha-Paul, Bert O'Neil, Sajeve Thomas, Martijn P Lolkema, Menghui Chen, Nageatte Ibrahim, Kevin Norwood, Julien Hadoux
Efficacy and Safety of Pembrolizumab in Previously Treated Advanced Neuroendocrine Tumors: Results From the Phase II KEYNOTE-158 Study. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (9) (2020)
Christophe Le Tourneau, Yungan Tao, Carlos Alberto Gomez Roca, Valerie Cristina, Edith Borcoman, Eric Deutsch, Rastislav Bahleda, Valentin Calugaru, Anouchka Modesto, Elisabeth Rouits, Kathrin Gollmer, Gregoire Vuagniaux, Philippa Crompton, Claudio Zanna, Sergio Szyldergemajn, Jean-Pierre Delord, Jean Bourhis
Phase I Trial of Debio 1143, an Antagonist of Inhibitor of Apoptosis Proteins, Combined with Cisplatin Chemoradiotherapy in Patients with Locally Advanced Squamous Cell Carcinoma of the Head and Neck. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (24) (2020)
Camille-Charlotte Balança, Clara-Maria Scarlata, Marie Michelas, Christel Devaud, Victor Sarradin, Camille Franchet, Carlos Martinez Gomez, Carlos Gomez-Roca, Marie Tosolini, Diana Heaugwane, Françoise Lauzéral-Vizcaino, Lucile Mir-Mesnier, Virginie Féliu, Carine Valle, Frédéric Pont, Gwenaël Ferron, Laurence Gladieff, Stéphanie Motton, Yann Tanguy Le Gac, Agnès Dupret-Bories, Jérôme Sarini, Benjamin Vairel, Claire Illac, Aurore Siegfried-Vergnon, Eliane Mery, Jean-Jacques Fournié, Sébastien Vergez, Jean-Pierre Delord, Philippe Rochaix, Alejandra Martinez, Maha Ayyoub
Dual Relief of T-lymphocyte Proliferation and Effector Function Underlies Response to PD-1 Blockade in Epithelial Malignancies. Cancer immunology research 8 (7) (2020)
Elena Elez, Carlos Gomez-Roca, Arturo Soto Matos-Pita, Guillem Argiles, Thibaud Valentin, Cinthya Coronado, Jorge Iglesias, Teresa Macarulla, Sarah Betrian, Salvador Fudio, Katrin Zaragoza, Josep Tabernero, Jean-Pierre Delord
First-in-human phase I study of the microtubule inhibitor plocabulin in patients with advanced solid tumors. Investigational new drugs 37 (4) (2018)
Sumanta K Pal, Jonathan E Rosenberg, Jean H Hoffman-Censits, Raanan Berger, David I Quinn, Matthew D Galsky, Juergen Wolf, Christian Dittrich, Bhumsuk Keam, Jean-Pierre Delord, Jan H M Schellens, Gwenaelle Gravis, Jacques Medioni, Pablo Maroto, Virote Sriuranpong, Chaiyut Charoentum, Howard A Burris, Viktor Gruenwald, Daniel Petrylak, Ulka Vaishampayan, Eliahu Gez, Ugo De Giorgi, Jae-Lyun Lee, Jens Voortman, Sumati Gupta, Sunil Sharma, Amir Mortazavi, David J Vaughn, Randi Isaacs, Katie Parker, Xueying Chen, Kun Yu, Dale Porter, Diana Graus Porta, Dean F Bajorin
Efficacy of BGJ398, a Fibroblast Growth Factor Receptor 1-3 Inhibitor, in Patients with Previously Treated Advanced Urothelial Carcinoma with FGFR3 Alterations. Cancer discovery 8 (7) (2018)
Nicolas Martin, Nicolas Isambert, Carlos Gomez-Roca, Rainer-Georg Goeldner, Sylvie Zanetta, Behbood Sadrolhefazi, Hélène de Mont-Serrat, Mario Campone, Jean-Pierre Delord
Phase I trial of afatinib and 3-weekly trastuzumab with optimal anti-diarrheal management in patients with HER2-positive metastatic cancer. Cancer chemotherapy and pharmacology 82 (6) (2018)
Alexandra Leary, Christophe Le Tourneau, Andrea Varga, Marie-Paule Sablin, Carlos Gomez-Roca, Nicolas Guilbaud, Aurelie Petain, Mariya Pavlyuk, Jean-Pierre Delord
Phase I dose-escalation study of F14512, a polyamine-vectorized topoisomerase II inhibitor, in patients with platinum-refractory or resistant ovarian cancer. Investigational new drugs 37 (4) (2018)

Jean-Pierre Delord.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Jean-Pierre Delord